Comprehensive Molecular Profiling of FLT3-Mutated Acute Myeloid Leukemia (AML) Patients Treated within the Ratify Trial (Alliance C10603)

被引：0

作者：

Jahn, Nikolaus ^{[1
]}

Panina, Ekaterina ^{[1
]}

Bullinger, Lars ^{[2
]}

Dolnik, Anna ^{[2
]}

Herzig, Julia ^{[1
]}

Blaette, Tamara J. ^{[2
]}

Benner, Axel ^{[3
]}

Krzykalla, Julia ^{[3
]}

Gathmann, Insa ^{[4
]}

Larson, Richard A. ^{[5
,6
]}

Lo-Coco, Francesco ^{[7
]}

Amadori, Sergio ^{[7
]}

Prior, Thomas W. ^{[8
]}

Brandwein, Joseph M. ^{[9
]}

Appelbaum, Frederick R. ^{[10
]}

Medeiros, Bruno C. ^{[11
]}

Tallman, Martin S. ^{[12
]}

Tiecke, Eva ^{[13
]}

Pallaud, Celine ^{[14
]}

Ehninger, Gerhard ^{[15
]}

Heuser, Michael ^{[16
]}

Ganser, Arnold ^{[16
]}

Stone, Richard M. ^{[17
]}

Thiede, Christian ^{[15
]}

Doehner, Hartmut ^{[1
]}

Bloomfield, Clara D. ^{[8
]}

Doehner, Konstanze ^{[1
]}

机构：

[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[2] Charite, Dept Hematol Oncol & Tumorimmunol, Berlin, Germany

[3] German Canc Res Ctr, Div Biostat, Heidelberg, Germany

[4] Novartis Pharma AG, Basel, Switzerland

[5] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA

[6] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA

[7] Univ Roma Tor Vergata, Rome, Italy

[8] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[9] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada

[10] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA

[11] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA

[12] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[13] Novartis Pharmaceut, Basel, Switzerland

[14] Novartis Pharmaceut, Oncol Precis Med, Novartis Oncol BU, Basel, Switzerland

[15] Univ Hosp Carl Gustav Carus, Internal Med 1, Dresden, Germany

[16] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[17] Dana Farber Partners CancerCare, Dept Med Oncol, Boston, MA USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-115842

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1534

引用

页数：6

共 50 条

[21] A Phase I/II Study of Gilteritinib and Momelotinib for Patients with Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Trial in Progress [J].

Short, Nicholas J. ;

Ravandi, Farhad ;

Daver, Naval ;

Dinardo, Courtney D. ;

Borthakur, Gautam ;

Kadia, Tapan M. ;

Yilmaz, Musa ;

Issa, Ghayas C. ;

Abramova, Regina ;

Garza, Araceli Isabella ;

Kantarjian, Hagop M. ;

Abbas, Hussein A. .

BLOOD, 2024, 144

[22] Outcomes of FLT3-Mutated Acute Myeloid Leukemia Patients: A Single Center Real-World Experience [J].

Shoukier, Mahran ;

Kota, Vamsi ;

Kolhe, Ravindra ;

Bryan, Locke J. ;

Jillella, Anand P. ;

Cortes, Jorge E. .

BLOOD, 2020, 136

[23] Evaluation of the Toxicity and Outcomes of the Combination of Midostaurin and CLAG-M in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML): A Multicenter Retrospective Analysis [J].

Chen, Ashley ;

Baek, Grace ;

Russell, Kathryn ;

Shaw, Carole ;

Othus, Megan ;

Cohen, Jonathan ;

Palmer, Shannon ;

Rasmussen, Jack ;

Bubalo, Joseph ;

Tsomo, Tenzin ;

Schwarz, Tenley ;

Namburi, Swathi ;

Halpern, Anna .

ANNALS OF PHARMACOTHERAPY, 2025, 59 (08) :703-713

[24] Low Relapse Rate in Younger Patients ≤ 60 Years Old with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) Treated with Crenolanib and Cytarabine/Anthracycline Chemotherapy [J].

Wang, Eunice S. ;

Tallman, Martin S. ;

Stone, Richard M. ;

Walter, Roland B. ;

Karanes, Chatchada ;

Jain, Vinay ;

Collins, Robert H. .

BLOOD, 2017, 130

[25] Lipopolymer/siRNA complexes engineered for optimal molecular and functional response with chemotherapy in FLT3-mutated acute myeloid leukemia [J].

Ansari, Aysha S. ;

Kucharski, Cezary ;

Kc, Remant ;

Nisakar, Daniel ;

Rahim, Ramea ;

Jiang, Xiaoyan ;

Brandwein, Joseph ;

Uludag, Hasan .

ACTA BIOMATERIALIA, 2024, 188 :297-314

[26] Prognostic Impact of NPM1/FLT3-ITD genotypes from Randomized Patients with Acute Myeloid Leukemia (AML) Treated within the International Ratify Study [J].

Dohner, Konstanze ;

Thiede, Christian ;

Larson, Richard A. ;

Prior, Thomas W. ;

Marcucci, Guido ;

Jones, Dan ;

Krauter, Jurgen ;

Heuser, Michael ;

Lo Coco, Francesco ;

Ottone, Tiziana ;

Nomdedeu, Josep ;

Mandrekar, Sumithra J. ;

Sanford, Ben L. ;

Laumann, Kristine ;

Geyer, Susan M. ;

Klisovic, Rebecca B. ;

Wei, Andrew ;

Sierra, Jorge ;

Sanz, Miguel A. ;

Brandwein, Joseph M. ;

de Witte, T. M. M. ;

Jansen, Joop H. ;

Niederwieser, Dietger ;

Appelbaum, Frederick R. ;

Medeiros, Bruno C. ;

Tallman, Martin S. ;

Schlenk, Richard F. ;

Ganser, Arnold ;

Serve, Hubert ;

Ehninger, Gerhard ;

Amadori, Sergio ;

Cheng, Yuan ;

Pallaud, Celine ;

Stone, Richard M. ;

Dohner, Hartmut ;

Bloomfield, Clara D. .

BLOOD, 2017, 130

[27] Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial [J].

Voso, Maria Teresa ;

Larson, Richard A. ;

Jones, Dan ;

Marcucci, Guido ;

Prior, Thomas ;

Krauter, Jurgen ;

Heuser, Michael ;

Lavorgna, Serena ;

Nomdedeu, Josep ;

Geyer, Susan M. ;

Walker, Alison ;

Wei, Andrew H. ;

Sierra, Jorge ;

Sanz, Miguel A. ;

Brandwein, Joseph M. ;

de Witte, Theo M. ;

Jansen, Joop H. ;

Niederwieser, Dietger ;

Appelbaum, Frederick R. ;

Medeiros, Bruno C. ;

Tallman, Martin S. ;

Schlenk, Richard F. ;

Ganser, Arnold ;

Amadori, Sergio ;

Cheng, Yuan ;

Chen, YinMiao ;

Pallaud, Celine ;

Du, Ling ;

Piciocchi, Alfonso ;

Ehninger, Gerhard ;

Byrd, John ;

Thiede, Christian ;

Dohner, Konstanze ;

Stone, Richard M. ;

Dohner, Hartmut ;

Bloomfield, Clara D. ;

Lo-Coco, Francesco .

BLOOD ADVANCES, 2020, 4 (19) :4945-4954

[28] Activity of Multiple Targetable Therapies in FLT3-Mutated (mu) Acute Myeloid Leukemia (AML) Patients (pts) with Concurrent Isocitrate Dehydrogenase Mutation (IDHm) [J].

Cortes, Jorge ;

Alfayez, Mansour ;

Kadia, Tapan M. ;

Konopleva, Marina Y. ;

Ravandi, Farhad ;

Cortes, Jorge E. ;

Jabbour, Elias ;

Garcia-Manero, Guillermo ;

Pierce, Sherry A. ;

Yilmaz, Musa E. ;

Short, Nicholas J. ;

Sasaki, Koji ;

Masarova, Lucia ;

Pemmaraju, Naveen ;

Borthakur, Gautam M. ;

Kantarjian, Hagop M. ;

DiNardo, Courtney D. ;

Daver, Naval G. .

BLOOD, 2019, 134

[29] AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial [J].

Mannelli, Francesco ;

Gianfaldoni, Giacomo ;

Guglielmelli, Paola ;

Buccisano, Francesco ;

Caporale, Roberto ;

Chiarini, Marco ;

Rossi, Giuseppe ;

Venditti, Adriano ;

Fazi, Paola ;

Crea, Enrico ;

Piciocchi, Alfonso ;

Voso, Maria Teresa ;

Vignetti, Marco ;

Amadori, Sergio ;

Vannucchi, Alessandro Maria .

FUTURE ONCOLOGY, 2021, 17 (29) :3787-3796

[30] Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib [J].

Perl, Alexander E. ;

Hosono, Naoko ;

Montesinos, Pau ;

Podoltsev, Nikolai ;

Martinelli, Giovanni ;

Panoskaltsis, Nicki ;

Recher, Christian ;

Smith, Catherine C. ;

Levis, Mark J. ;

Strickland, Stephen ;

Rollig, Christoph ;

Gross-Langenhoff, Marco ;

Chou, Wen-Chien ;

Lee, Je-Hwan ;

Yokoyama, Hisayuki ;

Hasabou, Nahla ;

Lu, Qiaoyang ;

Tiu, Ramon, V ;

Altman, Jessica K. .

BLOOD CANCER JOURNAL, 2022, 12 (05)

← 1 2 3 4 5 →